For many years, it has been known that aspirin is beneficial to patients suffering heart attacks and near-heart attacks. But which of the many different types of aspirin is likely to help the most? A group of researchers led by Dr. Sean Nordt from the University of California, San Diego gave three different...
Formulations Of Three Aspirin Types Compared By Study
A Feasible, Simple And Convenient Model For Study Of Rectal Carcinoma
The method of building a rabbit rectal VX2 carcinoma model by injecting the cell suspension of VX2 cells into the wall of the rectum guided by X-ray fluoroscopy is feasible. The advantages of the model are ease of establishment, short growth period, and high stability. The rectal VX2 carcinoma established...
ZymoGenetics Reports Encouraging Preliminary Results From Phase 2 Study Of IL-21 In Metastatic Melanoma Conducted By NCIC
ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that Interleukin 21 (IL-21) demonstrated an impressive overall response rate in the treatment of metastatic melanoma. In interim Phase 2 results from 24 patients, 29 percent showed a partial response, with an additional 33 percent of patients showing stable...
Medtronic Launches Large-Scale Clinical Trial To Examine Impact Of Implantable Device-Based Monitoring Technology On Heart Failure Patient Care
Medtronic, Inc. (NYSE: MDT) today announced the start of a nationwide trial to examine the relationship between the company’s OptiVol® Fluid Status Monitoring technology and the ability to predict worsening heart failure, a leading cause of hospitalizations worldwide. The trial will assess whether...
Enrollment Complete In The XCELL Trial - The First U.S. Study Of Stent Placement To Study Arterial Blockages Below The Knee
The XCELL trial, the first U.S. multicenter, prospective clinical trial to investigate the use of minimally invasive stent placement for severe peripheral arterial disease (PAD) below the knee, also referred to Critical Limb Ischemia (CLI), recently enrolled its 120th and final patient. The final patient...
“Let Our Children Play!” Congenital Heart Disease Charities Call For The End Of Exclusion From School Sports
The Children’s Heart Federation (CHF), an alliance of 22 charities that support children and young people with heart defects from birth or acquired in childhood, is using Children’s Heart Week (9-17 May 2009) to call for the full inclusion of heart children in PE at school and more opportunities...
Health Protection Agency Leads Work On Gaining Greater Understanding Of Swine Flu Virus
Scientists at the Health Protection Agency (HPA) have produced the first genetic fingerprint of the swine flu virus infecting humans across Europe. The virus’s entire genomic sequence will now be studied alongside other genetic information to give a greater understanding of how the virus behaves...
Results From Phase 3 EQUATE Trial Of VIVUS’ Qnexa Highlighted At European Congress On Obesity
VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, announced that data from the previously reported 28-week phase 3 EQUATE trial of Qnexa(TM) in obese patients are being presented at the 17th annual European Congress...
Poniard Pharmaceuticals To Present New Data From Phase 2 Clinical Trials Of Picoplatin In Multiple Tumor Types At The 45th Annual Meeting
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) announced that the Company will present new data from two ongoing Phase 2 clinical trials of picoplatin, the Company’s lead product candidate, at poster sessions during the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando....
New Guidance On Making Work Less Of A Pain In The Back
New guidance for employers, patients and doctors on helping people with back pain return to work will be announced on Tuesday May 5 at the University of Leicester. It is estimated that it costs society in excess of £12 billion a year with people taking time off work because of back pain. Around 80%...